Breadcrumb Home Yale Technologies Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE Yale Lifesciences Pitchfest 2018 12/12/2018 Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE Download Pitch Presentation 8_Bender_Blavatnik final#2 - for 5-8-18.pdf (285.59 KB) Investigators Jeffrey Bender, M.D. Robert I. Levy Professor of Medicine (Cardiology) and Professor of Immunobiology; Associate Chief, Cardiovascular Medicine, Internal Medicine; Director, Yale Cardiovascular Research Center, Internal Medicine
Jeffrey Bender, M.D. Robert I. Levy Professor of Medicine (Cardiology) and Professor of Immunobiology; Associate Chief, Cardiovascular Medicine, Internal Medicine; Director, Yale Cardiovascular Research Center, Internal Medicine
